The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Liposomes: Clinical Applications and Potential for Image-Guided Drug Delivery
Open accessAbstract
Liposomes have been extensively studied and are used in the treatment of several diseases. Liposomes improve the therapeutic efficacy by enhancing drug absorption while avoiding or minimizing rapid degradation and side effects, prolonging the biological half-life and reducing toxicity. The unique feature of liposomes is that they are biocompatible and biodegradable lipids, and are inert and non-immunogenic. Liposomes can compartmentalize and solubilize both hydrophilic and hydrophobic materials. All these properties of liposomes and their flexibility for surface modification to add targeting moieties make liposomes more attractive candidates for use as drug delivery vehicles. There are many novel liposomal formulations that are in various stages of development, to enhance therapeutic effectiveness of new and established drugs that are in preclinical and clinical trials. Recent developments in multimodality imaging to better diagnose disease and monitor treatments embarked on using liposomes as diagnostic tool. Conjugating liposomes with different labeling probes enables precise localization of these liposomal formulations using various modalities such as PET, SPECT, and MRI. In this review, we will briefly review the clinical applications of liposomal formulation and their potential imaging properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 1×
“Liposomes have been extensively studied in areas such as gene therapy [23] and drug delivery [24] due to their observed stability and favorable toxicity profile over traditional treatments.”
BackgroundDoxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Delivery materials for siRNA therapeutics
Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Torchilin, V. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4333 · Cited by 1,663
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Ernsting, M. J., Murakami, M., Roy, A., & Li, S.-D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,012
Haran, G., Cohen, R., Bar, L. K., & Barenholz, Y. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90105-9 · Cited by 934
Liposomal Drug Delivery Systems: An Update Review
Samad, A., Sultana, Y., & Aqil, M. (2007) · Current Drug Delivery · doi:10.2174/156720107782151269 · Cited by 906
Yeh, M.-K., Chang, H.-I., & Cheng, M.-Y. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s26766 · Cited by 801
Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety
Mukherjee, S., Date, A., Patravale, V., Korting, H. C., Roeder, A., & Weindl, G. (2006) · Clinical Interventions in Aging · doi:10.2147/ciia.2006.1.4.327 · Cited by 580
Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. M., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · PubMed · Cited by 575
Klibanov, A. L., Maruyama, K., Beckerleg, A. M., Torchilin, V. P., & Huang, L. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90385-l · Cited by 480
Liposome-based drug delivery in breast cancer treatment
Park, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr432 · Cited by 469
Tumour-inhibiting platinum complexes—state of the art and future perspectives
Jakupec, M. A., Galanski, M. S., & Keppler, B. K. (2003) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/s10254-002-0001-x · Cited by 434
Barriers to drug delivery in solid tumors
Sriraman, S. K., Aryasomayajula, B., & Torchilin, V. P. (2014) · Tissue Barriers · doi:10.4161/tisb.29528 · Cited by 338
Hansen, A. E., Petersen, A. L., Henriksen, J. R., Boerresen, B., Rasmussen, P., Elema, D. R., Rosenschöld, P. M. A., Kristensen, A. T., Kjær, A., & Andresen, T. L. (2015) · ACS Nano · doi:10.1021/acsnano.5b01324 · Cited by 277
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
Boulikas, T. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903114168 · Cited by 276
Advances in Platinum Chemotherapeutics
Harper, B. W., Krause‐Heuer, A. M., Grant, M. P., Manohar, M., Garbutcheon‐Singh, K. B., & Aldrich‐Wright, J. R. (2010) · Chemistry – A European Journal · doi:10.1002/chem.201000148 · Cited by 267
Gelation of liposome interior A novel method for drug encapsulation
Lasic, D. D., Frederik, P. M., Stuart, M. C. A., Barenholz, Y., & McIntosh, T. J. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80947-f · Cited by 261
An Overview of Cyclophosphamide Development and Clinical Applications
Colvin, O. M. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230110214512 · Cited by 246
Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome
Yang, T., Choi, M.-K., Cui, F.-D., Kim, J. S., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.011 · Cited by 245
Nanomedicine in Action: An Overview of Cancer Nanomedicine on the Market and in Clinical Trials
Wang, R., Billone, P. S., & Mullett, W. M. (2013) · Journal of Nanomaterials · doi:10.1155/2013/629681 · Cited by 236
Radiolabeled Nanoparticles for Multimodality Tumor Imaging
Xing, Y., Zhao, J., Conti, P. S., & Chen, K. (2014) · Theranostics · doi:10.7150/thno.7341 · Cited by 234
Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
Clancy, J. P., Dupont, L., Konstan, M. W., Billings, J., Fustik, S., Goss, C. H., Lymp, J., Minic, P., Quittner, A. L., Rubenstein, R. C., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202230 · Cited by 222
ChemInform Abstract: An Overview of Cyclophosphamide Development and Clinical Applications
Colvin, O. M. (1999) · ChemInform · doi:10.1002/chin.199951281 · Cited by 216
Functional Imaging of Inflammatory Diseases Using Nuclear Medicine Techniques
Basu, S., Zhuang, H., Torigian, D. A., Rosenbaum, J., Chen, W., & Alavi, A. (2009) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2008.10.006 · Cited by 213
Nanoparticulate Delivery Systems for Antiviral Drugs
Lembo, D., & Cavalli, R. (2010) · Antiviral Chemistry and Chemotherapy · doi:10.3851/imp1684 · Cited by 203
Targeted Liposomal Drug Delivery in Cancer
Medina, O., Zhu, Y., & Kairemo, K. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383467 · Cited by 200
Fahr, A., Hoogevest, P. V., May, S., Bergstrand, N., & S. Leigh, M. L. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.05.012 · Cited by 189
Zhigaltsev, I. V., Maurer, N., Akhong, Q.-F., Leone, R., Leng, E., Wang, J., Semple, S. C., & Cullis, P. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.010 · Cited by 186
Nagathihalli, N. S., Castellanos, J. A., Shi, C., Beesetty, Y., Reyzer, M. L., Caprioli, R., Chen, X., Walsh, A. J., Skala, M. C., Moses, H. L., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.058 · Cited by 184
Harrington, K. J., Lewanski, C. R., Northcote, A. D., Whittaker, J., Wellbank, H., Vile, R. G., Peters, A. M., & Stewart, J. S. W. (2001) · Annals of Oncology · doi:10.1023/a:1011199028318 · Cited by 182
Use of liposomes as injectable-drug delivery systems
Ostro, M. J., & Cullis, P. R. (1989) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/46.8.1576 · Cited by 177
Wolf, P., Müllegger, R. R., Peter Soyer, H., Hofer, A., Smolle, J., Horn, M., Cerroni, L., Hofmann-Wellenhof, R., Kerl, H., Maier, H., et al. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00839.x · Cited by 170
Chan, S. Y. T., Davidson, N. G. P., Juozaitytė, E., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh393 · Cited by 155
Astaxanthin inhibits cytotoxic and genotoxic effects of cyclophosphamide in mice germ cells
Tripathi, D. N., & Jena, G. (2008) · Toxicology · doi:10.1016/j.tox.2008.03.015 · Cited by 148
Thomson, A. B., Critchley, H., Kelnar, C. J. H., & Wallace, W. H. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0200 · Cited by 144
A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer
Kim, E. S., Lu, C., Khuri, F. R., Tonda, M. E., Glisson, B. S., Liu, D., Jung, M., Hong, W. K., & Herbst, R. S. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00278-1 · Cited by 136
Current Trends in Liposome Research
ElBayoumi, T. A., & Torchilin, V. P. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-360-2_1 · Cited by 136
64Cu loaded liposomes as positron emission tomography imaging agents
Petersen, A. L., Binderup, T., Rasmussen, P., Henriksen, J. R., Elema, D. R., Kjær, A., & Andresen, T. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.059 · Cited by 132
Nanocarriers for Nuclear Imaging and Radiotherapy of Cancer
Mitra, A., Nan, A., Line, B. R., et al. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779026317 · Cited by 130
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): Phase I study
Stathopoulos, G. P., Boulikas, T., Vougiouka, M., Deliconstantinos, G., Rigatos, S., Darli, E., Viliotou, V., & Stathopoulos, J. (2005) · Oncology Reports · doi:10.3892/or.13.4.589 · Cited by 128
Systemic Lipoplatin infusion results in preferential tumor uptake in human studies.
Boulikas, T., Stathopoulos, G. P., Volakakis, N., & Vougiouka, M. (2005) · PubMed · Cited by 126
Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin
Terwogt, J. M. M., Groenewegen, G., Pluim, D., Maliepaard, M., Tibben, M. M., Huisman, A., Huinink, W. W. T. B., Schot, M. E., Welbank, H., Voest, E. E., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100371 · Cited by 124
Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice.
Proffitt, R. T., Williams, L. E., Presant, C. A., Tin, G. W., Uliana, J. A., Gamble, R. C., & Baldeschwieler, J. D. (1983) · PubMed · Cited by 115
Long-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP)
Mařík, J., Tartis, M., Zhang, H., Fung, J. Y., Kheirolomoom, A., Sutcliffe-Goulden, J., & Ferrara, K. W. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.12.004 · Cited by 110
Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer.
Seetharamu, N., Kim, E., Höchster, H. S., Martin, F., & Muggia, F. M. (2010) · PubMed · Cited by 107
Paramagnetic liposomes for molecular MRI and MRI‐guided drug delivery
Langereis, S., Geelen, T., Grüll, H., Strijkers, G. J., & Nicolay, K. (2013) · NMR in Biomedicine · doi:10.1002/nbm.2971 · Cited by 107
Sterically stabilized liposomes labeled with indium-111 to image focal infection.
Boerman, O. C., Storm, G., Oyen, W. J. G., van Bloois, L., van der Meer, J. W., Claessens, R. A. M. J., Crommelin, D. J. A., & Corstens, F. H. M. (1995) · PubMed · Cited by 102
Semple, S. C., Leone, R., Wang, J., Leng, E. C., Klimuk, S. K., Eisenhardt, M. L., Yuan, Z.-N., Edwards, K., Maurer, N., Hope, M. J., et al. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20332 · Cited by 101
Nonviral Gene Delivery to Mesenchymal Stem Cells Using Cationic Liposomes for Gene and Cell Therapy
Madeira, C. G., Mendes, R. D., Ribeiro, S. C., Boura, J. S., Aires-Barros, M. R., da Silva, C. L., & Cabral, J. M. S. (2010) · BioMed Research International · doi:10.1155/2010/735349 · Cited by 97
Pérez‐Medina, C., Abdel-Atti, D., Zhang, Y., Longo, V. A., Irwin, C. P., Binderup, T., Ruíz-Cabello, J., Fayad, Z. A., Lewis, J. S., Mulder, W. J. M., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.141861 · Cited by 97
Harrington, K. J., Rowlinson‐Busza, G., Syrigos, K. N., Uster, P. S., Abra, R. M., & Stewart, J. S. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1232 · Cited by 96
Paxton, J. W. (2012) · InTech eBooks · doi:10.5772/1180 · Cited by 96
The Potential of Liposomes in Oral Drug Delivery
Rogers, J. A., & Anderson, K. E. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i5.10 · Cited by 94
Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation
de Jonge, M. J. A., Slingerland, M., Loos, W. J., Wiemer, E. A. C., Burger, H., Mathijssen, R. H. J., Kroep, J. R., den Hollander, M., van der Biessen, D. A. J., Lam, M.-H., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.015 · Cited by 92
Harrington, K. J., Rowlinson‐Busza, G., Syrigos, K. N., Abra, R. M., Uster, P. S., Peters, A. M., & Stewart, J. S. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1320 · Cited by 91
Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles
Phillips, W. T., Bao, A., Brenner, A. J., & Goins, B. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.001 · Cited by 89
Slingerland, M., Guchelaar, H., Rosing, H., Scheulen, M. E., van Warmerdam, L. J. C., Beijnen, J. H., & Gelderblom, H. A. J. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.10.009 · Cited by 89
Liposomal temozolomide drug delivery using convection enhanced delivery
Nordling‐David, M. M., Yaffe, R., Guez, D., Meirow, H., Last, D., Grad, E., Salomon, S., Sharabi, S., Levi‐Kalisman, Y., Golomb, G., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.028 · Cited by 89
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes.
Oyen, W. J. G., Boerman, O. C., Storm, G., van Bloois, L., Koenders, E. B., Claessens, R. A. M. J., Perenboom, R. M., Crommelin, D. J. A., van der Meer, J. W. M., & Corstens, F. H. M. (1996) · PubMed · Cited by 88
Eichhorn, M., Ischenko, I., Luedemann, S., Strieth, S., Papyan, A., Werner, A., Bohnenkamp, H. R., Guenzi, E., Preißler, G., Michaelis, U., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24846 · Cited by 85
Seiden, M. V., Muggia, F. M., Astrow, A., Matulonis, U. A., Campos, S., Roche, M. R., Sivret, J., Rusk, J., & Barrett, E. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.037 · Cited by 84
Bradbury, P. A., & Shepherd, F. A. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318174e9a7 · Cited by 83
Koshkina, N. V., Gilbert, B. E., Waldrep, J. C., Seryshev, A. B., & Knight, V. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050966 · Cited by 76
de Smet, M., Langereis, S., van den Bosch, S., Bitter, K., Hijnen, N. M., Heijman, E., & Grüll, H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.005 · Cited by 76
Phosphorus dendrimers for nanomedicine
Caminade, A. (2017) · Chemical Communications · doi:10.1039/c7cc04949h · Cited by 74
Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T2 Contrast Agents for MRI
Martínez-González, R., Estelrich, J., & Busquets, M. A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081209 · Cited by 72
Intrabilayer 64Cu Labeling of Photoactivatable, Doxorubicin-Loaded Stealth Liposomes
Luo, D., Goel, S., Liu, H., Carter, K. A., Jiang, D., Geng, J., Kutyreff, C. J., Engle, J. W., Huang, W., Shao, S., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b06578 · Cited by 72
Clinical application of high and ultra high-field MRI
Nakada, T. (2006) · Brain and Development · doi:10.1016/j.braindev.2006.10.005 · Cited by 69
PET imaging of brain cancer with positron emitter-labeled liposomes
Oku, N., Yamashita, M., Katayama, Y., Urakami, T., Hatanaka, K., Shimizu, K., Asai, T., Tsukada, H., Akai, S., & Kanazawa, H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.001 · Cited by 60
Tecemotide: An antigen-specific cancer immunotherapy
Wurz, G. T., Kao, C.-J., Wolf, M., & DeGregorio, M. W. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29836 · Cited by 59
Lee, H., Zheng, J., Gaddy, D. F., Orcutt, K. D., Leonard, S. C., Geretti, E., Hesterman, J. Y., Harwell, C., Hoppin, J., Jaffray, D. A., et al. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.08.011 · Cited by 59
Ma, M. K., Zamboni, W. C., Radomski, K. M., Furman, W. L., Santana, V. M., Houghton, P. J., Hanna, S. K., Smith, A. K., & Stewart, C. F. (2000) · PubMed · Cited by 58
Jensen, A. I., Severin, G. W., Hansen, A. E., Fliedner, F. P., Eliasen, R., Parhamifar, L., Kjær, A., Andresen, T. L., & Henriksen, J. R. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.006 · Cited by 55
Victories and deceptions in tumor immunology
Kroemer, G., Zitvogel, L., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.23687 · Cited by 54
In-111-labeled liposomes: dosimetry and tumor depiction.
Turner, A., Presant, C. A., Proffitt, R. T., Williams, L. E., Winsor, D. W., & Werner, J. L. (1988) · Radiology · doi:10.1148/radiology.166.3.3340774 · Cited by 53
Chow, T.-H., Lin, Y.-Y., Hwang, J., Wang, H.-E., Tseng, Y., Pang, V. F., Liu, R.-S., Lin, W., Yang, C., & Ting, G. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.063503 · Cited by 48
Development of 111 In-Labeled Liposomes for Vulnerable Atherosclerotic Plaque Imaging
Ogawa, M., Umeda, I. O., Kosugi, M., Kawai, A., Hamaya, Y., Takashima, M., Hongxia, Y., Kudoh, T., Seno, M., & Magata, Y. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.123158 · Cited by 48
MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies
Ren, L., Chen, S., Li, H., et al. (2015) · Nanoscale · doi:10.1039/c5nr02144h · Cited by 46
Liposomes containing paramagnetic macromolecules as MRI contrast agents
Navon, G., Panigel, R., & Valensin, G. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030608 · Cited by 45
Wetzler, M., Thomas, D. A., Wang, E. S., Shepard, R. C., Ford, L. A., Heffner, T. L., Parekh, S. S., Andreeff, M., O'Brien, S. M., & Kantarjian, H. M. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.03.015 · Cited by 45
Radionuclide imaging of liposomal drug delivery
van der Geest, T., Laverman, P., Metselaar, J. M., Storm, G., & Boerman, O. C. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1205584 · Cited by 45
Optimal radiolabeled liposomes for tumor imaging.
Umeda, I. O., Sasaki, T., Kojima, S., & Nishigori, H. (1996) · PubMed · Cited by 44
Tseng, W., & Huang, L. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00054-6 · Cited by 42
Seo, J. W., Qin, S., Mahakian, L. M., Watson, K. D., Kheirolomoom, A., & Ferrara, K. W. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.008 · Cited by 41
[18F]-Fluorinated Carboplatin and [111In]-Liposome for Image-Guided Drug Delivery
Lamichhane, N., Dewkar, G. K., Sundaresan, G., Mahon, R. N., & Zweit, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051079 · Cited by 40
Self-citationDifferential uptake of gallium-67-labeled liposomes between tumors and inflammatory lesions in rats.
Ogihara, I., Kojima, S., & Jay, M. (1986) · PubMed · Cited by 39
Wu, H., Ramanathan, R. K., Zamboni, B. A., Strychor, S., Ramalingam, S. S., Edwards, R. P., Friedland, D., Stoller, R. G., Belani, C. P., Maruca, L. J., et al. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010394851 · Cited by 39
Soundararajan, A., Dodd, G. D., Bao, A., Phillips, W. T., McManus, L. M., Prihoda, T. J., & Goins, B. (2011) · Radiology · doi:10.1148/radiol.11110361 · Cited by 39
Awasthi, V., Goins, B., Klipper, R. W., & Phillips, W. T. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00162-5 · Cited by 38
Arlinghaus, R. B., Lopez‐Berestein, G., Belmont, J. W., Rosenblum, M. G., Sun, T., Stephens, C. L., Monaco, G., Gutiérrez-Puente, Y., & Tari, A. M. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.5.1243 · Cited by 38
Kim, H. R., You, D. G., Park, S.-J., Choi, K., Um, W., Kim, J., Park, J. H., & Kim, Y. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00013 · Cited by 35
Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging
Ding, N., Ding, N., Lü, Yang, C., Huang, Liu, Xiang, ■., & Lee (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s23934 · Cited by 34
Huang, F.-Y. J., Lee, T., Kao, C. K., Chang, C.-H., Zhang, X., Lee, W., Chen, W.-J., Wang, S., & Lo, J. (2011) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2011.1052 · Cited by 34
Doubly radiolabeled liposomes for pretargeted radioimmunotherapy
Mougin‐Degraef, M., Bourdeau, C., Jestin, E., Maurel, C., Bourgeois, M., Saëc, P. L., Thédrez, P., Gestin, J., Barbet, J., & Faivre-Chauvet, A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.024 · Cited by 34
Indium-111-labelled liposomes: dosimetry and tumour detection in patients with cancer
Kubo, A., Nakamura, K., Sammiya, T., Katayama, M., Hashimoto, T., Hashimoto, S., Kobayashi, H., & Teramoto, T. (1993) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00168869 · Cited by 33
Espinola, L. G., Beaucaire, J., GOTTSCHALK, A. R., & Caride, V. J. (1979) · PubMed · Cited by 32
Ito, K., Hamamichi, S., Asano, M., Hori, Y., Matsui, J., Iwata, M., Funahashi, Y., Umeda, I. O., & Fujii, H. (2015) · Cancer Science · doi:10.1111/cas.12841 · Cited by 30
Increased delivery of gallium-67 to tumors using serum-stable liposomes.
Umeda, I. O., & Kojima, S. (1988) · PubMed · Cited by 30
The use and importance of liposomes in Positron Emission Tomography
Silindir‐Gunay, M., Özer, A. Y., & Erdoğan, S. (2012) · Drug Delivery · doi:10.3109/10717544.2011.635721 · Cited by 28
Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01
Ashizawa, A. T., & Cortes, J. E. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.996545 · Cited by 28
Kneepkens, E., Fernandes, A., Nicolay, K., & Grüll, H. (2016) · Investigative Radiology · doi:10.1097/rli.0000000000000297 · Cited by 27
Wong, A. W., Ormsby, E. L., Zhang, H., Seo, J. W., Mahakian, L. M., Caskey, C. F., & Ferrara, K. W. (2013) · PubMed Central · Cited by 25
Design of Hydrated Porphyrin-Phospholipid Bilayers with Enhanced Magnetic Resonance Contrast
Shao, S., Do, T. N., Razi, A., Chitgupi, U., Geng, J., Alsop, R. J., Dzikovski, B. G., Rheinstadter, M. C., Ortega, J., Karttunen, M., et al. (2016) · Small · doi:10.1002/smll.201602505 · Cited by 25
Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors
Umeda, I. O., & Kojima, S. (1989) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00256940 · Cited by 22
Multimodal liposomes for SPECT/MR imaging as a tool for in situ relaxivity measurements
de Vries, A., Kok, M. B., Sanders, H. M. H. F., Nicolay, K., Strijkers, G. J., & Grüll, H. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.468 · Cited by 17
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Lombardo, D., & Kiselev, M. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030543 · Cited by 718
Thi, T. T. H., Suys, E. J. A., Lee, J. S., Nguyen, D. H., Park, K. D., & Truong, N. P. (2021) · Vaccines · doi:10.3390/vaccines9040359 · Cited by 525
Nanomedicine review: clinical developments in liposomal applications
Beltrán-Gracia, E., López-Camacho, A., Higuera-Ciapara, I., Velázquez-Fernández, J. B., & Vallejo-Cardona, A. A. (2019) · Cancer Nanotechnology · doi:10.1186/s12645-019-0055-y · Cited by 513
Metadata
- Authors
- Lamichhane, N., Udayakumar, T., D’Souza, W., Simone II, C., Raghavan, S., Polf, J., & Mahmood, J.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-01-30
- Volume
- 23
- Issue
- 2
- Pages
- 288
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2791490604
- Cited by
- 303
- References
- 115
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.